PharmGen Science, Inc. (KRX:004720)
South Korea · Delayed Price · Currency is KRW 3,030.00
+5.00 (0.17%)
Sep 14, 2026, 1:02 PM KST
PharmGen Science Market Cap
PharmGen Science has a market cap or net worth of 68.4 billion as of September 11, 2026. Its market cap has decreased by -18.93% in one year.
Market Cap
68.40B
Enterprise Value
73.75B
Revenue
171.66B
Ranking
n/a
PE Ratio
580.92
Stock Price
3,030.00
ChartMarket Cap Chart
Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 68.40B, an increase of 528.01%. That is a compound annual growth rate of 6.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 68.40B | -24.87% |
| Dec 30, 2025 | 91.05B | 22.74% |
| Dec 30, 2024 | 74.18B | -33.39% |
| Dec 28, 2023 | 111.36B | 5.58% |
| Dec 29, 2022 | 105.47B | -33.88% |
| Dec 30, 2021 | 159.51B | -3.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 65.43T |
| Celltrion | 42.77T |
| ALTEOGEN | 18.66T |
| Samsung Epis Holdings | 8.44T |
| DK Life Science | 71.00B |
| Ildong Holdings | 70.51B |
| Cellid, | 69.33B |
| Sugentech | 69.26B |